Sunwoo 2013.
| Methods | Study design: randomised controlled cross‐over trial Number of dropouts: not stated Number of adverse effects: 3 (mild headache after real dual‐tDCS) Deaths: not stated ITT: unclear |
|
| Participants | Country: Republic of Korea Sample size: 10 chronic stroke patients (mean age 63 years) with left unilateral visuospatial neglect after stroke Inclusion criteria: not explicitly stated except written informed consent Exclusion criteria: metallic implants in the head; skull defect; history of seizure; uncontrolled medical problems; severe cognitive impairment |
|
| Interventions | Each participant underwent all of the following conditions (separated by a resting period of at least 24 hours)
|
|
| Outcomes | Outcomes were measured at baseline and at the end of stimulation
|
|
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Quote: "All patients participated in dual, single, and sham tDCSsessions at intervals of at least 24 hours between sessions in a randomized order" |
| Allocation concealment (selection bias) | Unclear risk | Not described by the authors |
| Blinding of participants and personnel (performance bias) Subjective outcome measures | Low risk | Participants were blinded, whereas blinding of personnel was not stated. However, the review authors judge that the outcome measurement is not likely to be influenced by lack of blinding |
| Blinding of participants and personnel (performance bias) Objective outcome measures | Low risk | Participants were blinded, whereas blinding of personnel was not stated. However, the review authors judge that the outcome measurement is not likely to be influenced by lack of blinding |
| Blinding of outcome assessment (detection bias) Subjective outcome measures | Low risk | Outcome assessor was blinded; quote: "Both tests were performed by a single examiner who was blinded to the type of stimulation" |
| Blinding of outcome assessment (detection bias) Objective outcome measures | Low risk | Outcome assessor was blinded; quote: "Both tests were performed by a single examiner who was blinded to the type of stimulation" |
| Incomplete outcome data (attrition bias) Subjective outcome measures | Unclear risk | All participants apparently completed the study. No treatment withdrawals, no losses to follow‐up, no trial group changes and no major adverse events were stated |
| Incomplete outcome data (attrition bias) Objective outcome measures | Unclear risk | All participants apparently completed the study. No treatment withdrawals, no losses to follow‐up, no trial group changes and no major adverse events were stated |
| Selective reporting (reporting bias) | Unclear risk | All outcome measures listed in the methods section have been reported |